In addition, the synthetic analogues of vitamin D activate the VDR activator to arrest the pancreatic cancer cell cycle at G1 by downregulating expression of both β-catenin and AKT [10, 28]. The gene discussed is AKT1; the disease is pancreatic neoplasm.